 Shares of Cumberland NASDAQ:CPIX rose 2.07 in after-market trading after the company reported Q2 results.Quarterly Results Earnings per share decreased 20.00 year over year to 0.08, which beat the estimate of 0.03.Revenue of 9,598,000 decreased by 17.12 from the same period last year, which beat the estimate of 9,270,000.Looking Ahead Earnings guidance hasnt been issued by the company for now.Cumberland hasnt issued any revenue guidance for the time being.How To Listen To The Conference Call Date: Aug 11, 2020View more earnings on CPIXTime: 04:30 PMET Webcast URL: Stock Performance Companys 52-week high was at 6.10Companys 52-week low was at 3.10Price action over last quarter: down 5.87Company Overview Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It focuses on the acquisition, development, and commercialization of branded prescription products. The company provides prescription products to hospital acute care and gastroenterology to address unmet or poorly met medical needs. Its product brands include Acetadote, Caldolor, Kristalose, Omeclamox- Pak, Vaprisol and Ethyol.See more from Benzinga Earnings Scheduled For August 11, 2020 Earnings Preview: CumberlandC 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. 